Javier Valero Fonseca
Neurology · Modesto, CANPI 1972642239
Payments from drug & device makers
Across 262 payments — averaging $19.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$2K
- Livanova USA, Inc.$518
- Supernus Pharmaceuticals, Inc.$411
- Greenwich Biosciences, Inc.$221
- Sunovion Pharmaceuticals Inc.$206
- Aucta Pharmaceuticals, Inc.$192
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,031100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 113 | $1,798 |
| Livanova USA, Inc. | 17 | $518 |
| Supernus Pharmaceuticals, Inc. | 17 | $411 |
| Greenwich Biosciences, Inc. | 11 | $221 |
| Sunovion Pharmaceuticals Inc. | 13 | $206 |
| Aucta Pharmaceuticals, Inc. | 9 | $192 |
| Novartis | 9 | $175 |
| Acadia Pharmaceuticals Inc | 5 | $131 |
| Regeneron Healthcare Solutions, Inc. | 6 | $129 |
| Azurity Pharmaceuticals, Inc. | 5 | $112 |
| Neurelis, Inc. | 5 | $101 |
| PTC Therapeutics, Inc. | 4 | $92 |
| Novo Nordisk | 4 | $86 |
| Eisai Inc. | 4 | $81 |
| Aquestive Therapeutics, Inc. | 4 | $78 |
| Ipsen Biopharmaceuticals, Inc | 3 | $70 |
| Masimo Corporation | 2 | $61 |
| Sarepta Therapeutics, Inc. | 4 | $56 |
| Zogenix Inc. | 3 | $55 |
| Cranial Technologies, Inc | 3 | $48 |
| EMD Serono, Inc. | 1 | $45 |
| Amneal Pharmaceuticals LLC | 2 | $43 |
| Kyowa Kirin, Inc. | 2 | $42 |
| Nestle Healthcare Nutrition Inc. | 2 | $40 |
| SK Life Science, Inc. | 2 | $37 |
| QOL Medical, LLC | 2 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 1 | $21 |
| AstraZeneca | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| AbbVie | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| Albireo Pharma, Inc. | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$125
- VNS Therapy$108
How this compares
$5,031 in reported general payments places this provider in the 60th percentile of 1,996 neurology providers in California.
Other neurology in Modesto
- Timothy CloughesyLos Angeles$33.1M
- Jack FlorinFullerton$13M
- David KudrowSanta Monica$12.8M
- John Ravitsla Jolla$8.4M
- Perminder BhatiaFresno$8.3M
- Perry ShiehLos Angeles$8.2M
- Benjamin FrishbergCarlsbad$8.2M
- Bruce CreeSan Francisco$8M
- Lawrence RechtPalo Alto$6.6M
- Stanley PrusinerSan Francisco$6.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.